Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

312 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Randomized phase II study of gemcitabine plus radiotherapy versus gemcitabine, 5-fluorouracil, and cisplatin followed by radiotherapy and 5-fluorouracil for patients with locally advanced, potentially resectable pancreatic adenocarcinoma.
Landry J, Catalano PJ, Staley C, Harris W, Hoffman J, Talamonti M, Xu N, Cooper H, Benson AB 3rd. Landry J, et al. Among authors: talamonti m. J Surg Oncol. 2010 Jun 1;101(7):587-92. doi: 10.1002/jso.21527. J Surg Oncol. 2010. PMID: 20461765 Free PMC article. Clinical Trial.
Initial results of a phase II trial of high dose radiation therapy, 5-fluorouracil, and cisplatin for patients with anal cancer (E4292): an Eastern Cooperative Oncology Group study.
Martenson JA, Lipsitz SR, Wagner H Jr, Kaplan EH, Otteman LA, Schuchter LM, Mansour EG, Talamonti MS, Benson AB 3rd. Martenson JA, et al. Among authors: talamonti ms. Int J Radiat Oncol Biol Phys. 1996 Jul 1;35(4):745-9. doi: 10.1016/0360-3016(96)00146-0. Int J Radiat Oncol Biol Phys. 1996. PMID: 8690640 Clinical Trial.
Eastern Cooperative Oncology Group Phase I trial of protracted venous infusion fluorouracil plus weekly gemcitabine with concurrent radiation therapy in patients with locally advanced pancreas cancer: a regimen with unexpected early toxicity.
Talamonti MS, Catalano PJ, Vaughn DJ, Whittington R, Beauchamp RD, Berlin J, Benson AB 3rd. Talamonti MS, et al. J Clin Oncol. 2000 Oct 1;18(19):3384-9. doi: 10.1200/JCO.2000.18.19.3384. J Clin Oncol. 2000. PMID: 11013279 Clinical Trial.
Pancreatic adenocarcinoma: Clinical Practice Guidelines in Oncology.
Tempero MA, Behrman S, Ben-Josef E, Benson AB 3rd, Cameron JL, Casper ES, Hoffman JP, Karl RC, Kim P, Koh WJ, Kuvshinoff BW 2nd, Melvin WS, Muscarella P 2nd, Sasson AR, Shibata S, Shrieve DC, Talamonti MS, Tyler DS, Vickers SM, Warren RS, Willett C, Wolff RA; National Comprehensive Cancer Network. Tempero MA, et al. Among authors: talamonti ms. J Natl Compr Canc Netw. 2005 Sep;3(5):598-626. doi: 10.6004/jnccn.2005.0035. J Natl Compr Canc Netw. 2005. PMID: 16194453 No abstract available.
A multi-institutional phase II trial of preoperative full-dose gemcitabine and concurrent radiation for patients with potentially resectable pancreatic carcinoma.
Talamonti MS, Small W Jr, Mulcahy MF, Wayne JD, Attaluri V, Colletti LM, Zalupski MM, Hoffman JP, Freedman GM, Kinsella TJ, Philip PA, McGinn CJ. Talamonti MS, et al. Ann Surg Oncol. 2006 Feb;13(2):150-8. doi: 10.1245/ASO.2006.03.039. Epub 2006 Jan 19. Ann Surg Oncol. 2006. PMID: 16418882 Free article. Clinical Trial.
312 results